← Leaderboards
Thomas J Braciale
University Of Virginia Charlottesville
$22,435,148
Attributed
$23,667,833
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$31,761,785 · 13
By mechanism
R01$18,431,480 · 6
U19$10,158,667 · 4
T32$2,402,933 · 1
R21$434,500 · 1
R37$334,205 · 1
Top collaborators
- Tina V Hartert3 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Coleen A McNamara$22,811,214
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionInfluenzaLungVirusImmuneLaboratoriesCellsInjuryVirus DiseasesImmune ResponseRespiratory SystemDesignImmune SystemCytokineResponsePneumoniaMediatingProgramsVirus ReplicationLaboratory MouseRecoveryT-LymphocyteCd8b1 GeneRespiratory Tract Structure
Grant awards (74)
Control of Influenza Infection by Lipid Mediators and Macrophages$549,761
R01 · FY2021 · AI · contact PI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza$636,629
R01 · FY2020 · AI
Control of Influenza Infection by Lipid Mediators and Macrophages$549,761
R01 · FY2020 · AI · contact PI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza$702,593
R01 · FY2019 · AI
Control of Influenza Infection by Lipid Mediators and Macrophages$549,761
R01 · FY2019 · AI · contact PI
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza$1,126,149
R01 · FY2018 · AI
Control of Influenza Infection by Lipid Mediators and Macrophages$548,909
R01 · FY2018 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$395,000
R01 · FY2017 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$395,000
R01 · FY2016 · AI · contact PI
Adipokines in Pulmonary Viral Infection$197,500
R21 · FY2016 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$404,486
R01 · FY2015 · AI · contact PI
Adipokines in Pulmonary Viral Infection$237,000
R21 · FY2015 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$453,500
R01 · FY2014 · AI · contact PI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection$1,478,707
U19 · FY2013 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$371,300
R01 · FY2013 · AI · contact PI
Interleukin-10 in acute respiratory virus infection$283,730
U19 · FY2013 · AI · contact PI
Administration$67,340
U19 · FY2013 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$51,384
R01 · FY2013 · AI · contact PI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection$1,573,092
U19 · FY2012 · AI · contact PI
T Cell Function in Pulmonary Viral Pulmonary Infection and Injury$372,672
R01 · FY2012 · HL · contact PI
Interleukin-10 in acute respiratory virus infection$283,259
U19 · FY2012 · AI · contact PI
Administration$104,508
U19 · FY2012 · AI · contact PI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection$1,572,425
U19 · FY2011 · AI · contact PI
T Cell Function in Pulmonary Viral Pulmonary Infection and Injury$376,526
R01 · FY2011 · HL · contact PI
Interleukin-10 in acute respiratory virus infection$251,629
U19 · FY2011 · AI · contact PI
Administration$127,439
U19 · FY2011 · AI · contact PI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection$1,573,733
U19 · FY2010 · AI · contact PI
T Cell Function in Pulmonary Viral Pulmonary Infection and Injury$376,609
R01 · FY2010 · HL · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$357,172
R01 · FY2010 · AI · contact PI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection$338,804
U19 · FY2010 · AI · contact PI
Interleukin-10 in acute respiratory virus infection$251,500
U19 · FY2010 · AI · contact PI
Administration$127,376
U19 · FY2010 · AI · contact PI
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection$1,557,191
U19 · FY2009 · AI · contact PI
T Cell Function in Pulmonary Viral Pulmonary Infection and Injury$376,691
R01 · FY2009 · HL · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$360,779
R01 · FY2009 · AI · contact PI
Interleukin-10 in acute respiratory virus infection$248,267
U19 · FY2009 · AI · contact PI
Administration$126,542
U19 · FY2009 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$360,779
R01 · FY2008 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$367,766
R01 · FY2007 · AI · contact PI
CD8+ T cell trafficking to the normal lung$361,494
R01 · FY2007 · HL · contact PI
T Cell Function in Pulmonary Viral Infection and Injury$349,802
R01 · FY2007 · HL · contact PI
Immunobiology of Experimental RSV Infection$324,001
R01 · FY2007 · AI · contact PI
An Interdisciplinary Training Program in Immmunology$384,210
T32 · FY2006 · AI · contact PI
Cytotoxic T Lymphocyte Response to Influenza Virus$379,792
R01 · FY2006 · AI · contact PI
CD8+ T cell trafficking to the normal lung$372,291
R01 · FY2006 · HL · contact PI
T Cell Function in Pulmonary Viral Infection and Injury$360,280
R01 · FY2006 · HL · contact PI
Immunobiology of Experimental RSV Infection$335,062
R01 · FY2006 · AI · contact PI
CD8+ T cell trafficking to the normal lung$380,521
R01 · FY2005 · HL
T Cell Function in Pulmonary Viral Infection and Injury$368,981
R01 · FY2005 · HL
Cytotoxic T Lymphocyte Response to Influenza Virus$368,877
R01 · FY2005 · AI
An Interdisciplinary Training Program in Immmunology$368,617
T32 · FY2005 · AI
Immunobiology of Experimental RSV Infection$342,563
R01 · FY2005 · AI
T Cell Function in Pulmonary Viral Infection and Injury$369,011
R01 · FY2004 · HL
Cytotoxic T Lymphocyte Response to Influenza Virus$368,920
R01 · FY2004 · AI
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY$361,400
T32 · FY2004 · AI
CD8+ T cell trafficking to the normal lung$342,000
R01 · FY2004 · HL
Immunobiology of Experimental RSV Infection$340,715
R01 · FY2004 · AI
T Cell Function in Pulmonary Viral Infection and Injury$369,040
R01 · FY2003 · HL
Cytotoxic T Lymphocyte Response to Influenza Virus$368,962
R01 · FY2003 · AI
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY$349,779
T32 · FY2003 · AI
Immunobiology of Experimental RSV Infection$170,376
R01 · FY2003 · AI
Cytotoxic T Lymphocyte Response to Influenza Virus$369,002
R01 · FY2002 · AI
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY$341,174
T32 · FY2002 · AI
T CELL FUNCITON IN PULMONARY VIRAL INFECTION AND INJURY$325,774
R01 · FY2002 · HL
IMMUNOBIOLOGY OF EXPERIMENTAL RSV INFECTION$281,242
R01 · FY2002 · AI
Cytotoxic T Lymphocyte Response to Influenza Virus$332,136
R01 · FY2001 · AI
T CELL FUNCITON IN PULMONARY VIRAL INFECTION AND INJURY$317,604
R01 · FY2001 · HL
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY$311,026
T32 · FY2001 · AI
IMMUNOBIOLOGY OF EXPERIMENTAL RSV INFECTION$273,721
R01 · FY2001 · AI
CYTOTOXIC T LYMPHOCYTE RESPONSE TO INFLUENZA VIRUS$334,205
R37 · FY2000 · AI
T CELL FUNCITON IN PULMONARY VIRAL INFECTION AND INJURY$309,667
R01 · FY2000 · HL
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY$286,727
T32 · FY2000 · AI
IMMUNOBIOLOGY OF EXPERIMENTAL RSV INFECTION$266,419
R01 · FY2000 · AI
RESPIRATORY SYNCYTIAL VIRUS AND ATOPIC PULMONARY RESPONSE$193,125
U19 · FY2000 · AI